Clinical Trial Update: Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

View source ↗

Summary

Real-world study of olaparib use and clinical outcomes in ovarian cancer patients in France, Italy, and the United Kingdom.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovary Cancer | Status: COMPLETED